Cancer Drug Discovery Using Fragment-Based Methods
Time: 11:15 am
day: Conf Day 1
Details:
- Drugging highly validated cancer targets that are challenging to drug
- Inhibiting KRAS, MYC, and the WNT pathway
- Using fragment-based methods and structure-based design
